Klain: Pharma will be net winner in exchange with Trump administration

1:06 PM ET Tue, 31 Jan 2017

Ronald Klain, former White House senior advisor, and Vamil Divan, Credit Suisse pharma analyst, weigh in on President Trump's plans to bring down drug prices and the potential impact on the pharmaceutical industry. With CNBC's Meg Tirrell.